Inhibrx Stock Volatility

INBX -  USA Stock  

USD 23.20  1.79  7.16%

Inhibrx holds Efficiency (Sharpe) Ratio of -0.15, which attests that the entity had -0.15% of return per unit of risk over the last 3 months. Macroaxis standpoint towards determining the risk of any stock is to look at both systematic and unsystematic factors of the business, including all available market data and technical indicators. Inhibrx exposes twenty-eight different technical indicators, which can help you to evaluate volatility that cannot be diversified away. Please be advised to check out Inhibrx risk adjusted performance of (0.1), and Market Risk Adjusted Performance of (0.37) to validate the risk estimate we provide.

Inhibrx Volatility 

 
Refresh
Inhibrx Stock volatility depicts how high the prices fluctuate around the mean (or its average) price. In other words, it is a statistical measure of the distribution of Inhibrx daily returns, and it is calculated using variance and standard deviation. We also use Inhibrx's beta, its sensitivity to the market, as well as its odds of financial distress to provide a more practical estimation of Inhibrx volatility.

60 Days Market Risk

Not too volatile

Chance of Distress

Below Average

60 Days Economic Sensitivity

Responds to the market
Since volatility provides investors with entry points to take advantage of stock prices, companies, such as Inhibrx can benefit from it. Downward market volatility can be a perfect environment for investors who play the long game. Here, they may decide to buy additional stocks of Inhibrx at lower prices. For example, an investor can purchase Inhibrx stock that has halved in price over a short period. This will lower your average cost per share, thereby improving your portfolio's performance when the markets normalize. Similarly, when the prices of Inhibrx's stock rises, investors can sell out and invest the proceeds in other equities with better opportunities. Investing when markets are volatile with better valuations will accord both investors and companies the opportunity to generate better long-term returns.

Inhibrx Market Sensitivity And Downside Risk

Inhibrx's beta coefficient measures the volatility of Inhibrx stock compared to the systematic risk of the entire stock market represented by your selected benchmark. In mathematical terms, beta represents the slope of the line through a regression of data points where each of these points represents Inhibrx stock's returns against your selected market. In other words, Inhibrx's beta of 1.44 provides an investor with an approximation of how much risk Inhibrx stock can potentially add to one of your existing portfolios.
Let's try to break down what Inhibrx's beta means in this case. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Inhibrx will likely underperform.
3 Months Beta |Analyze Inhibrx Demand Trend
Check current 90 days Inhibrx correlation with market (DOW)

Inhibrx Beta

    
  1.44  
Inhibrx standard deviation measures the daily dispersion of prices over your selected time horizon relative to its mean. Typical volatile equity has a high standard deviation, while the deviation of a stable instrument is usually low. As a downside, the standard deviation calculates all uncertainty as risk, even when it is in your favor, such as above-average returns.

Standard Deviation

    
  4.43  
It is essential to understand the difference between upside risk (as represented by Inhibrx's standard deviation) and the downside risk, which can be measured by semi-deviation or downside deviation of Inhibrx stock's daily returns or price. Since the actual investment returns on holding a position in Inhibrx stock tend to have a non-normal distribution, there will be different probabilities for losses than for gains. The likelihood of losses is reflected in the downside risk of an investment in Inhibrx.

Inhibrx Stock Volatility Analysis

Volatility refers to the frequency at which Inhibrx stock price increases or decreases within a specified period. These fluctuations usually indicate the level of risk that's associated with Inhibrx's price changes. Investors will then calculate the volatility of Inhibrx's stock to predict their future moves. A stock that has erratic price changes quickly hits new highs, and lows are considered highly volatile. A stock with relatively stable price changes has low volatility. A highly volatile stock is riskier, but the risk cuts both ways. Investing in highly volatile security can either be highly successful, or you may experience significant failure. There are two main types of Inhibrx's volatility:

Historical Volatility

This type of stock volatility measures Inhibrx's fluctuations based on previous trends. It's commonly used to predict Inhibrx's future behavior based on its past. However, it cannot conclusively determine the future direction of the stock.

Implied Volatility

This type of volatility provides a positive outlook on future price fluctuations for Inhibrx's current market price. This means that the stock will return to its initially predicted market price.
Transformation
The output start index for this execution was zero with a total number of output elements of sixty-one. Inhibrx Average Price is the average of the sum of open, high, low and close daily prices of a bar. It can be used to smooth an indicator that normally takes just the closing price as input. View also all equity analysis or get more info about average price price transform indicator.

Inhibrx Projected Return Density Against Market

Given the investment horizon of 90 days the stock has the beta coefficient of 1.4441 . This usually indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Inhibrx will likely underperform.
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Inhibrx or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Inhibrx stock's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Inhibrx stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
The company has a negative alpha, implying that the risk taken by holding this instrument is not justified. Inhibrx is significantly underperforming DOW.
 Predicted Return Density 
      Returns 
Inhibrx's volatility is measured either by using standard deviation or beta. Standard deviation will reflect the average amount of how Inhibrx stock's price will differ from the mean after some time.To get its calculation, you should first determine the mean price during the specified period then subtract that from each price point.

What Drives a Company's Stock Price Volatility?

Several factors can influence a company's stock volatility:

Industry

Specific events can influence volatility within a particular industry. For instance, a significant weather upheaval in a crucial oil-production site may cause oil prices to increase in the oil sector. The direct result will be the rise in the stock price of oil distribution companies. Similarly, any government regulation in a specific industry could negatively influence stock prices due to increased regulations on compliance that may impact the company's future earnings and growth.

Political and Economic environment

When governments make significant decisions regarding trade agreements, policies, and legislation regarding specific industries, they will influence stock prices. Everything from speeches to elections may influence investors, who can directly influence the stock prices in any particular industry. The prevailing economic situation also plays a significant role in stock prices. When the economy is doing well, investors will have a positive reaction and hence, better stock prices and vice versa.

The Company's Performance

Sometimes volatility will only affect an individual company. For example, a revolutionary product launch or strong earnings report may attract many investors to purchase the company. This positive attention will raise the company's stock price. In contrast, product recalls and data breaches may negatively influence a company's stock prices.

Inhibrx Stock Risk Measures

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Inhibrx or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Inhibrx stock's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Inhibrx stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
Given the investment horizon of 90 days the coefficient of variation of Inhibrx is -663.44. The daily returns are distributed with a variance of 19.59 and standard deviation of 4.43. The mean deviation of Inhibrx is currently at 3.03. For similar time horizon, the selected benchmark (DOW) has volatility of 0.83
α
Alpha over DOW
-0.45
β
Beta against DOW1.44
σ
Overall volatility
4.43
Ir
Information ratio -0.11

Inhibrx Stock Return Volatility

Inhibrx historical daily return volatility represents how much Inhibrx stock's price daily returns swing around its mean daily price change - it is a statistical measure of its dispersion of returns. The company inherits 4.4256% risk (volatility on return distribution) over the 90 days horizon. By contrast, DOW inherits 0.8429% risk (volatility on return distribution) over the 90 days horizon.
 Performance (%) 
      Timeline 

About Inhibrx Volatility

Volatility is a rate at which the price of Inhibrx or any other equity instrument increases or decreases for a given set of returns. It is measured by calculating the standard deviation of the annualized returns over a given period of time and shows the range to which the price of Inhibrx may increase or decrease. In other words, similar to Inhibrx's beta indicator, it measures the risk of Inhibrx and helps estimate the fluctuations that may happen in a short period of time. So if prices of Inhibrx fluctuate rapidly in a short time span, it is termed to have high volatility, and if it swings slowly in a more extended period, it is understood to have low volatility.
Please read more on our technical analysis page.
Last ReportedProjected for 2022
Market Capitalization1.1 B1.1 B
Inhibrx, Inc., a clinical-stage biotechnology company, focuses on developing a pipeline of novel biologic therapeutic candidates. Its therapeutic candidates include INBRX-109, a tetravalent agonist of death receptor 5, which is in Phase 1 clinical trials in patients with solid tumors, including sarcoma and INBRX-105, an tetravalent conditional agonist of programmed death ligand 1 and a conditional agonist of 4-1BB that is in Phase 1 clinical trials to treat patients with PD-L1 expressing tumors. The companys therapeutic candidates also comprise INBRX-101, an Fc fusion protein therapeutic candidate, which is in Phase 1 clinical trials for use in the treatment of patients with alpha-1 antitrypsin deficiency. Its preclinical programs include INBRX-106, a single domain antibody based hexavalent agonist of OX40 for a range of oncology indications. Inhibrx, Inc. was founded in 2010 and is headquartered in La Jolla, California.

Inhibrx Investment Opportunity

Inhibrx has a volatility of 4.43 and is 5.27 times more volatile than DOW. 38  of all equities and portfolios are less risky than Inhibrx. Compared to the overall equity markets, volatility of historical daily returns of Inhibrx is lower than 38 () of all global equities and portfolios over the last 90 days. Use Inhibrx to protect your portfolios against small market fluctuations. The stock experiences a very speculative upward sentiment. Check odds of Inhibrx to be traded at $22.04 in 90 days. . Let's try to break down what Inhibrx's beta means in this case. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Inhibrx will likely underperform.

Modest diversification

The correlation between Inhibrx and DJI is Modest diversification for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Inhibrx and DJI in the same portfolio assuming nothing else is changed.

Inhibrx Additional Risk Indicators

The analysis of Inhibrx's secondary risk indicators is one of the essential steps in making a buy or sell decision. The process involves identifying the amount of risk involved in Inhibrx's investment and either accepting that risk or mitigating it. Along with some common measures of Inhibrx stock risk such as standard deviation, beta, or value at risk, we also provide a set of secondary indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Risk Adjusted Performance(0.1)
Market Risk Adjusted Performance(0.37)
Mean Deviation2.99
Coefficient Of Variation(797.66)
Standard Deviation4.35
Variance18.92
Information Ratio(0.11)
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential stock investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Inhibrx Suggested Diversification Pairs

Pair trading is one of the very effective strategies used by professional day traders and hedge funds capitalizing on short-time and mid-term market inefficiencies. The approach is based on the fact that the ratio of prices of two correlating shares is long-term stable and oscillates around the average value. If the correlation ratio comes outside the common area, you can speculate with a high success rate that the ratio will return to the mean value and collect a profit.
Ford vs. Inhibrx
Salesforce vs. Inhibrx
GM vs. Inhibrx
Visa vs. Inhibrx
Sentinelone Inc vs. Inhibrx
Alphabet vs. Inhibrx
Microsoft Corp vs. Inhibrx
Du Pont vs. Inhibrx
Dividend Appreciation vs. Inhibrx
The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against Inhibrx as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. Inhibrx's systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, Inhibrx's unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to Inhibrx.
Please see Risk vs Return Analysis. Note that the Inhibrx information on this page should be used as a complementary analysis to other Inhibrx's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.

Complementary Tools for Inhibrx Stock analysis

When running Inhibrx price analysis, check to measure Inhibrx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inhibrx is operating at the current time. Most of Inhibrx's value examination focuses on studying past and present price action to predict the probability of Inhibrx's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Inhibrx's price. Additionally, you may evaluate how the addition of Inhibrx to your portfolios can decrease your overall portfolio volatility.
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Go
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Go
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Go
Is Inhibrx's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Inhibrx. If investors know Inhibrx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Inhibrx listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Inhibrx is measured differently than its book value, which is the value of Inhibrx that is recorded on the company's balance sheet. Investors also form their own opinion of Inhibrx's value that differs from its market value or its book value, called intrinsic value, which is Inhibrx's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Inhibrx's market value can be influenced by many factors that don't directly affect Inhibrx's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Inhibrx's value and its price as these two are different measures arrived at by different means. Investors typically determine Inhibrx value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Inhibrx's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.